South Korean umbilical cord blood bank Hucord chosen for 6 Stem Cell Therapy Companies by Nature Biotechnology journal

신태섭 기자l승인2022.03.25l수정2022.03.25 14:15

크게

작게

메일

인쇄

신고

   
 

Cord blood is a blood collected from the vein of umbilical cord and the amount is around 100 to 200cc. Cord blood contains stem cells that are roots of cartilages, bones, muscles and neurons and for this reason they are being used in the regenerative medicine and curing incurable diseases. 

Some families keep their cord blood for the use in the future. The problem is the expensive keeping fee. Paying attention on this high cost, Hucord is running an umbilical cord blood bank that can be used for the public. 

Junhong Kim, CEO of Hucord, says that possibility of using one's own umbilical cord blood is less than 0.04%. A leukemia patient, for example, already has leukemia precursor cell in his cord blood so using the cord blood is useless. But transplant of cord blood from different HLA genes is possible with rare possibility of occurring graft versus host disease. In other words, Kim says, using other people's cord blood should not arouse a big issue in terms of safety. 

Currently, Hucord is keeping around 80,000 units of cord bloods that meet the international standards. Keeping alongside are testing records and all necessary information including HLA. The company has accumulated data on stem cell tests and disease treatments for a long time and is producing unique stem cells and culture media through differentiated stem cell culture techniques. 

Its HSCM culture media is used for its various derma cosmetic lines including toner, ample, cream and serum and they are sold on the market with excellent reviews at the moment. Hucord's HSCM is rich in multi bio substances and the team avoids any forms of artificial blend during the making process in order to make it as natural as possible. It is registered in the International Cosmetic Ingredient Dictionary and Handbook. 

"We signed a export deal worth $2 million with a buyer in China in August 2020 and a memorandum of understanding with a buyer from Malaysia. We are receiving inquiries from buyers in the US and Japan at the moment which is encouraging" says Kim.

Hucord has 10 patents for original technologies in cord blood and its stem cells and was listed in the 6 Stem Cell Therapy Companies by Nature Biotechnology journal in December 2005. The company is giving out cord blood for 200 blood cancer patients for free alongside free membership for families in financial difficulty. <PowerKorea>

PowerKorea is an official partner of Herald Corporation and the magazine is distributed to the KOTRA business centers in the world. We publish latest news of Samsung, Hyundai and government affairs and endeavor to serve as a platform to engage with people around the world. 


신태섭 기자  tss79@naver.com
<저작권자 © 월간파워코리아, 무단 전재 및 재배포 금지>

신태섭 기자의 다른기사 보기
가장 많이 본 기사
여백
여백
신문사소개기사제보광고문의불편신고개인정보취급방침청소년보호정책이메일무단수집거부
㈜뉴스앤매거진 파워코리아 대표 백종원  |   서울특별시 광진구 중곡동 162-3번지 2층  |  대표전화 : 02-466-5085  |  팩스 : 02-444-0454
대표메일/제휴광고문의 : bridgekorea@naver.com  |  개인정보관리책임자 : 백종원(bridgekorea@naver.com)  |  사업자등록번호 : 591-87-01957
청소년보호책임자 : 백종원
Disclaimer: PowerKorea makes an article based on the information of products and/or services provided in paper and/or in interview by the company, the organization or the person that is solely responsible for the information.
Copyright © 2008 - 2022 월간파워코리아. All rights reserved.